
Lindsay Grayson REFERENCE: Abstract K-1374, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 LINDSAY GRAYSON, Austin Hospital, Victoria, Australia A

Jennifer Lavrrar, Jane Hata, Jeanette Block REFERENCE: Slide Session C2-1360, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JANE HATA, bioMérÃeu

Moira McMahon REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 MOIRA MCMAHON, Johns Hopkins University, Baltimore The hepatitis B drug ente

Jeffrey Jacobson REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JEFFREY JACOBSON, Drexel University College of Medicine, Philadelphia Cou

Jacob Lalezari REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JACOB LALEZARI, Quest Clinical Research, San Francisco Maraviroc could be a

Diana Lockwood REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 DIANA LOCKWOOD, London School of Hygiene and Tropical Medicine ICAAC delega

Georg Härter REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 GEORG HÄRTER, University Hospital, Ulm For patients with multiple myeloma b

Donna Hacek REFERENCE: Slide Session 42 K-608, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 DONNA HACEK, Evanston Hospital, Evanston Illinois Tho

Megan Nguyen REFERENCE: Poster Session 104 K-1096, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 MEGAN NGUYEN, Western University in Pomona, Calif

Jon Otter REFERENCE: Poster Session 033 K-464, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JON OTTER, Bioquell Ltd, Andover UK An investigation

Shekhar Saxena Mental Health is a major part of the global disease burden, but more needs to be done to make sure support, treatments and policies are in place. That’s according to a series of a